Cargando…

Epigenetic differences in monozygotic twins discordant for major depressive disorder

Although monozygotic (MZ) twins share the majority of their genetic makeup, they can be phenotypically discordant on several traits and diseases. DNA methylation is an epigenetic mechanism that can be influenced by genetic, environmental and stochastic events and may have an important impact on indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Malki, K, Koritskaya, E, Harris, F, Bryson, K, Herbster, M, Tosto, M G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931599/
https://www.ncbi.nlm.nih.gov/pubmed/27300265
http://dx.doi.org/10.1038/tp.2016.101
_version_ 1782440926281465856
author Malki, K
Koritskaya, E
Harris, F
Bryson, K
Herbster, M
Tosto, M G
author_facet Malki, K
Koritskaya, E
Harris, F
Bryson, K
Herbster, M
Tosto, M G
author_sort Malki, K
collection PubMed
description Although monozygotic (MZ) twins share the majority of their genetic makeup, they can be phenotypically discordant on several traits and diseases. DNA methylation is an epigenetic mechanism that can be influenced by genetic, environmental and stochastic events and may have an important impact on individual variability. In this study we explored epigenetic differences in peripheral blood samples in three MZ twin studies on major depressive disorder (MDD). Epigenetic data for twin pairs were collected as part of a previous study using 8.1-K-CpG microarrays tagging DNA modification in white blood cells from MZ twins discordant for MDD. Data originated from three geographical regions: UK, Australia and the Netherlands. Ninety-seven MZ pairs (194 individuals) discordant for MDD were included. Different methods to address non independently-and-identically distributed (non-i.i.d.) data were evaluated. Machine-learning methods with feature selection centered on support vector machine and random forest were used to build a classifier to predict cases and controls based on epivariations. The most informative variants were mapped to genes and carried forward for network analysis. A mixture approach using principal component analysis (PCA) and Bayes methods allowed to combine the three studies and to leverage the increased predictive power provided by the larger sample. A machine-learning algorithm with feature reduction classified affected from non-affected twins above chance levels in an independent training-testing design. Network analysis revealed gene networks centered on the PPAR−γ (NR1C3) and C-MYC gene hubs interacting through the AP-1 (c-Jun) transcription factor. PPAR−γ (NR1C3) is a drug target for pioglitazone, which has been shown to reduce depression symptoms in patients with MDD. Using a data-driven approach we were able to overcome challenges of non-i.i.d. data when combining epigenetic studies from MZ twins discordant for MDD. Individually, the studies yielded negative results but when combined classification of the disease state from blood epigenome alone was possible. Network analysis revealed genes and gene networks that support the inflammation hypothesis of MDD.
format Online
Article
Text
id pubmed-4931599
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49315992016-07-05 Epigenetic differences in monozygotic twins discordant for major depressive disorder Malki, K Koritskaya, E Harris, F Bryson, K Herbster, M Tosto, M G Transl Psychiatry Original Article Although monozygotic (MZ) twins share the majority of their genetic makeup, they can be phenotypically discordant on several traits and diseases. DNA methylation is an epigenetic mechanism that can be influenced by genetic, environmental and stochastic events and may have an important impact on individual variability. In this study we explored epigenetic differences in peripheral blood samples in three MZ twin studies on major depressive disorder (MDD). Epigenetic data for twin pairs were collected as part of a previous study using 8.1-K-CpG microarrays tagging DNA modification in white blood cells from MZ twins discordant for MDD. Data originated from three geographical regions: UK, Australia and the Netherlands. Ninety-seven MZ pairs (194 individuals) discordant for MDD were included. Different methods to address non independently-and-identically distributed (non-i.i.d.) data were evaluated. Machine-learning methods with feature selection centered on support vector machine and random forest were used to build a classifier to predict cases and controls based on epivariations. The most informative variants were mapped to genes and carried forward for network analysis. A mixture approach using principal component analysis (PCA) and Bayes methods allowed to combine the three studies and to leverage the increased predictive power provided by the larger sample. A machine-learning algorithm with feature reduction classified affected from non-affected twins above chance levels in an independent training-testing design. Network analysis revealed gene networks centered on the PPAR−γ (NR1C3) and C-MYC gene hubs interacting through the AP-1 (c-Jun) transcription factor. PPAR−γ (NR1C3) is a drug target for pioglitazone, which has been shown to reduce depression symptoms in patients with MDD. Using a data-driven approach we were able to overcome challenges of non-i.i.d. data when combining epigenetic studies from MZ twins discordant for MDD. Individually, the studies yielded negative results but when combined classification of the disease state from blood epigenome alone was possible. Network analysis revealed genes and gene networks that support the inflammation hypothesis of MDD. Nature Publishing Group 2016-06 2016-06-14 /pmc/articles/PMC4931599/ /pubmed/27300265 http://dx.doi.org/10.1038/tp.2016.101 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Malki, K
Koritskaya, E
Harris, F
Bryson, K
Herbster, M
Tosto, M G
Epigenetic differences in monozygotic twins discordant for major depressive disorder
title Epigenetic differences in monozygotic twins discordant for major depressive disorder
title_full Epigenetic differences in monozygotic twins discordant for major depressive disorder
title_fullStr Epigenetic differences in monozygotic twins discordant for major depressive disorder
title_full_unstemmed Epigenetic differences in monozygotic twins discordant for major depressive disorder
title_short Epigenetic differences in monozygotic twins discordant for major depressive disorder
title_sort epigenetic differences in monozygotic twins discordant for major depressive disorder
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931599/
https://www.ncbi.nlm.nih.gov/pubmed/27300265
http://dx.doi.org/10.1038/tp.2016.101
work_keys_str_mv AT malkik epigeneticdifferencesinmonozygotictwinsdiscordantformajordepressivedisorder
AT koritskayae epigeneticdifferencesinmonozygotictwinsdiscordantformajordepressivedisorder
AT harrisf epigeneticdifferencesinmonozygotictwinsdiscordantformajordepressivedisorder
AT brysonk epigeneticdifferencesinmonozygotictwinsdiscordantformajordepressivedisorder
AT herbsterm epigeneticdifferencesinmonozygotictwinsdiscordantformajordepressivedisorder
AT tostomg epigeneticdifferencesinmonozygotictwinsdiscordantformajordepressivedisorder